FRESENIUS KABI PHARMA PORTUGAL secures contract for Based On Cpa 2026_4 - Lipids 200 Mg/Ml Emul Inj Fr 100 Ml Iv

Portugal, Oct. 6 -- Portugal based FRESENIUS KABI PHARMA PORTUGAL has secured contract from Unidade Local De Saude De Coimbra, E. P. E. for Based On Cpa 2026_4 - Lipids 200 Mg/Ml Emul Inj Fr 100 Ml Iv. The value of the contract is worth 1668 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....